Under construction – not a live service
Sign in
Not yet taking people in United StatesNo phase

Using glucose sensors to find hidden diabetes in dialysis patients

Tests whether wearable glucose sensors detect undiagnosed diabetes in adults on dialysis.

Plain-language title generated from the registry record
Registry title: Unmasking Diabetes in Dialysis With Continuous Glucose Monitoring

Key facts

Where
Atlanta, United StatesSee the site

Where in United States

  • Grady Memorial HospitalAtlanta, United StatesNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Emory University
Trial code
NCT07880795
Record updated
27 October 2026
Original description
This study will evaluate whether Continuous Glucose Monitoring (CGM) can identify previously unrecognized diabetes and clinically significant hyperglycemia in adults with end-stage kidney disease (ESKD) receiving hemodialysis who have no known history of diabetes.Read full original descriptionShow less

Unmasking Diabetes in Dialysis With Continuous Glucose Monitoring

This study will evaluate whether Continuous Glucose Monitoring (CGM) can identify previously unrecognized diabetes and clinically significant hyperglycemia in adults with end-stage kidney disease (ESKD) receiving hemodialysis who have no known history of diabetes.

Participants will wear a CGM sensor for up to 15 days and undergo standard diabetes assessments, including fasting plasma glucose and hemoglobin.

The primary objectives are to:

* Determine the prevalence of previously undiagnosed diabetes among dialysis patients using OGTT criteria. * Compare CGM glucose patterns between participants with and without diabetes as determined by OGTT results.

Inclusion: Dialysis treatment for more than 3 months; Willing to wear a CGM for at least 10 days and to undergo an OGTT.

Exclusion: History of diabetes or use of insulin or any diabetes treatment in the past; Allergy to medical-grade adhesives; Pregnant or planning to become pregnant during the study.

ClinicalTrials.gov NCT07880795